CEACAM1 and cancer: For example, sialic acid-binding immunoglobulin-like lectins (SIGLECs) and carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) are expressed by activated NK cells and their blockade enhances NK cell cytotoxicity against cancer cells [51,52].